FIELD: medicine.
SUBSTANCE: favourable physiological revascularisation of ischemic retinal tissue is stimulated by the introduction of therapeutically effective amount of an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS).
EFFECT: invention provides both inhibition of pathologic neovascularisation, and effective stimulation of physiological revascularisation of ischemic retina ensured by the selection of specified angiostatic agent.
5 cl, 4 ex, 8 dwg
Authors
Dates
2010-10-10—Published
2006-02-24—Filed